Eric Venker, President & Immunovant CEO at Roivant Sciences Ltd. (ROIV), sold 200,000 shares at $29.59 ($5.9M) on 2026-04-20, disclosed to the SEC on 2026-04-22.
Seasonal sale ($5.9M) by President & Immunovant CEO — this insider has traded ROIV in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ROIV | SELL | 2026-09-01 | $7.2M | — | Filing → |
| ROIV | SELL | 2026-07-29 | $7.0M | — | Filing → |
| IMVT | SELL | 2026-07-06 | $119K | — | Filing → |